pfizer’s-big-gamble-is-paying-off-its-stock-is-a-good-long-term-bet.

Pfizer’s Big Gamble Is Paying Off. Its Stock Is a Good Long-Term Bet.


  • Order Reprints

  • Print Article


Illustration by Jason Lyon

Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.

“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins:…